132 related articles for article (PubMed ID: 34579701)
1. Evaluation of a rapid one-step PSA test for primary prostate cancer screening.
Ashida S; Yamasaki I; Kawada C; Fukuhara H; Fukata S; Tamura K; Karashima T; Inoue K; Shuin T
BMC Urol; 2021 Sep; 21(1):135. PubMed ID: 34579701
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a new, rapid, qualitative, one-step PSA Test for prostate cancer screening: the PSA RapidScreen test.
Miano R; Mele GO; Germani S; Bove P; Sansalone S; Pugliese PF; Micali F
Prostate Cancer Prostatic Dis; 2005; 8(3):219-23. PubMed ID: 15897915
[TBL] [Abstract][Full Text] [Related]
3. Baseline PSA in a Spanish male population aged 40-49 years anticipates detection of prostate cancer.
Angulo JC; Viñas MA; Gimbernat H; Fata FR; Granados R; Luján M
Actas Urol Esp; 2015 Dec; 39(10):605-11. PubMed ID: 26099906
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of malignant prostatic cells detection in blood for early detection of prostate cancer: comparison to prostatic biopsy.
Murray NP; Reyes E; Tapia P; Orellana N; Dueñas R; Fuentealba C; Badinez L
Arch Esp Urol; 2011 Dec; 64(10):961-71. PubMed ID: 22228894
[TBL] [Abstract][Full Text] [Related]
5. The Cost-Effectiveness of Prostate Cancer Detection with the Use of Prostate Health Index.
Heijnsdijk EA; Denham D; de Koning HJ
Value Health; 2016; 19(2):153-7. PubMed ID: 27021748
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study.
Grönberg H; Adolfsson J; Aly M; Nordström T; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Clements M; Egevad L; Eklund M
Lancet Oncol; 2015 Dec; 16(16):1667-76. PubMed ID: 26563502
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of an immunochromatographical assay, PSA Rapid Test as a primary screening test for prostate cancer.
Shigeno K; Arichi N; Yoneda T; Kishi H; Shiina H; Igawa M
Int Urol Nephrol; 2006; 38(3-4):565-9. PubMed ID: 17111081
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a rapid qualitative prostate specific antigen assay, the One Step PSA(TM) test.
Dok An C; Yoshiki T; Lee G; Okada Y
Cancer Lett; 2001 Jan; 162(2):135-9. PubMed ID: 11146217
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A
J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
[TBL] [Abstract][Full Text] [Related]
10. Clinical usefulness of free PSA in early detection of prostate cancer.
Luboldt HJ; Swoboda A; Börgermann C; Fornara P; Rübben H;
Onkologie; 2001 Feb; 24(1):33-7. PubMed ID: 11441278
[TBL] [Abstract][Full Text] [Related]
11. Sudden PSA rise to ≥20 ng/ml and prostate cancer diagnosis in the United States: A population-based study.
Vilson FL; Li S; Brooks JD; Eisenberg ML
Prostate; 2020 Dec; 80(16):1438-1443. PubMed ID: 32956488
[TBL] [Abstract][Full Text] [Related]
12. Opportunistic testing versus organized prostate-specific antigen screening: outcome after 18 years in the Göteborg randomized population-based prostate cancer screening trial.
Arnsrud Godtman R; Holmberg E; Lilja H; Stranne J; Hugosson J
Eur Urol; 2015 Sep; 68(3):354-60. PubMed ID: 25556937
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a rapid quantitative determination method of PSA concentration with gold immunochromatographic strips.
Wu CC; Lin HY; Wang CP; Lu LF; Yu TH; Hung WC; Houng JY; Chung FM; Lee YJ; Hu JJ
BMC Urol; 2015 Nov; 15():109. PubMed ID: 26530738
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer screening by prostate-specific antigen (PSA); a relevant approach for the small population of the Cayman Islands.
Jyoti SK; Blacke C; Patil P; Amblihalli VP; Nicholson A
Cancer Causes Control; 2018 Jan; 29(1):87-92. PubMed ID: 28918559
[TBL] [Abstract][Full Text] [Related]
15. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
Faria EF; Carvalhal GF; dos Reis RB; Tobias-Machado M; Vieira RA; Reis LO; Nogueira L; Machado RD; Freitas CH; Magnabosco WJ; Mauad EC; Carvalho AL
BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057
[TBL] [Abstract][Full Text] [Related]
16. [Clinical value of prostate specific antigen screening in early detection of prostate cancer].
Hua LX; Qiao D; Song NH; Feng NH; Yang J; Zhang JX; Chen JG; Zhang W; Sui YG; Wu HF
Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):705-9. PubMed ID: 20021870
[TBL] [Abstract][Full Text] [Related]
17. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves.
Catalona WJ; Richie JP; deKernion JB; Ahmann FR; Ratliff TL; Dalkin BL; Kavoussi LR; MacFarlane MT; Southwick PC
J Urol; 1994 Dec; 152(6 Pt 1):2031-6. PubMed ID: 7525994
[TBL] [Abstract][Full Text] [Related]
18. Efficiency of prostate-specific antigen and digital rectal examination in screening, using 4.0 ng/ml and age-specific reference range as a cutoff for abnormal values.
Crawford ED; Leewansangtong S; Goktas S; Holthaus K; Baier M
Prostate; 1999 Mar; 38(4):296-302. PubMed ID: 10075009
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen assay using whole blood samples spotted on filter paper and its application to mass screening for prostate cancer.
Nanri M; Nanri K; Fujiyama C; Tokuda Y; Nakamura K; Uozumi J
Int J Urol; 2007 Jun; 14(6):505-9. PubMed ID: 17593094
[TBL] [Abstract][Full Text] [Related]
20. Rate of change in serum prostate specific antigen levels as a method for prostate cancer detection.
Smith DS; Catalona WJ
J Urol; 1994 Oct; 152(4):1163-7. PubMed ID: 7520949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
